Nonendothelium-dependent dysfunction is generally manifested as metabolic disorders of ET-1, which induces the contraction of vascular smooth muscle and leads to excessive contraction of microvasculature by being combined with the corresponding receptor on vascular smooth muscle [25]. The gene discussed is EDN1; the disease is metabolic disease.